WallStSmart

AMN Healthcare Services Inc (AMN)vsDaVita HealthCare Partners Inc (DVA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DaVita HealthCare Partners Inc generates 305% more annual revenue ($13.84B vs $3.42B). DVA leads profitability with a 5.7% profit margin vs -0.9%. DVA appears more attractively valued with a PEG of 0.65. DVA earns a higher WallStSmart Score of 70/100 (B-).

AMN

Buy

62

out of 100

Grade: C+

Growth: 7.3Profit: 4.0Value: 6.3Quality: 5.5
Piotroski: 4/9Altman Z: 2.27

DVA

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 5.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMNUndervalued (+60.2%)

Margin of Safety

+60.2%

Fair Value

$49.13

Current Price

$31.69

$17.44 discount

UndervaluedFair: $49.13Overvalued
DVASignificantly Overvalued (-17.0%)

Margin of Safety

-17.0%

Fair Value

$123.34

Current Price

$192.16

$68.82 premium

UndervaluedFair: $123.34Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMN3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
99.9%10/10

Revenue surging 99.9% year-over-year

EPS GrowthGrowth
321.3%10/10

Earnings expanding 321.3% YoY

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

DVA4 strengths · Avg: 9.0/10
Return on EquityProfitability
81.0%10/10

Every $100 of equity generates 81 in profit

Debt/EquityHealth
-17.5010/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.658/10

Growing faster than its price suggests

EPS GrowthGrowth
43.5%8/10

Earnings expanding 43.5% YoY

Areas to Watch

AMN4 concerns · Avg: 3.0/10
PEG RatioValuation
1.714/10

Expensive relative to growth rate

Market CapQuality
$1.17B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.093/10

Elevated debt levels

Return on EquityProfitability
-4.5%2/10

ROE of -4.5% — below average capital efficiency

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
5.7%3/10

5.7% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AMN

The strongest argument for AMN centers on Revenue Growth, EPS Growth, Price/Book. Revenue growth of 99.9% demonstrates continued momentum.

Bull Case : DVA

The strongest argument for DVA centers on Return on Equity, Debt/Equity, PEG Ratio. PEG of 0.65 suggests the stock is reasonably priced for its growth.

Bear Case : AMN

The primary concerns for AMN are PEG Ratio, Market Cap, Debt/Equity.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

AMN profiles as a hypergrowth stock while DVA is a value play — different risk/reward profiles.

DVA carries more volatility with a beta of 0.91 — expect wider price swings.

AMN is growing revenue faster at 99.9% — sustainability is the question.

AMN generates stronger free cash flow (555M), providing more financial flexibility.

Bottom Line

DVA scores higher overall (70/100 vs 62/100). AMN offers better value entry with a 60.2% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

AMN Healthcare Services Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

AMN Healthcare Services, Inc. provides healthcare personnel solutions and staffing services to hospitals and healthcare facilities in the United States. The company is headquartered in Dallas, Taxas.

Visit Website →

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

Want to dig deeper into these stocks?